09.02.2013 Views

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(A61K) I.1(1)<br />

(21) 10827544.7 (22) 29.10.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

(86) US 2010/054779 29.10.2010<br />

(87) WO 2011/053812 2011/18 05.05.2011<br />

(30) 30.10.2009 US 256701 P<br />

22.04.2010 US 326991 P<br />

22.04.2010 US 326989 P<br />

22.04.2010 US 326982 P<br />

22.04.2010 US 326986 P<br />

23.04.2010 US 327474 P<br />

26.04.2010 US 327914 P<br />

27.04.2010 US 328491 P<br />

03.05.2010 US 330624 P<br />

05.05.2010 US 331704 P<br />

16.06.2010 US 355430 P<br />

20.10.2010 US 405073 P<br />

20.10.2010 US 405080 P<br />

20.10.2010 US 405075 P<br />

20.10.2010 US 405084 P<br />

(54) VERFAHREN ZUR BEHANDLUNG VON VI-<br />

RUSERKRANKUNGEN<br />

METHODS OF TREATING VIRAL ASSO-<br />

CIATED DISEASES<br />

PROCÉDÉS DE TRAITEMENT DE MALA-<br />

DIES ASSOCIÉES À DES VIRUS<br />

(71) Chimerix, Inc., 2505 Meridian Parkway, Suite<br />

340, Durham, NC 27713, US<br />

(72) PAINTER, George, R., Chapel Hill North<br />

Carolina 27514, US<br />

LANIER, Ernest, Randall, Chapel Hill North<br />

Carolina 27516, US<br />

PAINTER, Wendy, Chapel Hill North Carolina<br />

27514, US<br />

(74) Ireland, Jacqueline Frances, et al, Mintz<br />

Levin Cohn Ferris Glovsky and Popeo Intellectual<br />

Property LLP Alder Castle 10 Noble<br />

Street, GB-London EC2V 7JX, GB<br />

A61K 31/70<strong>36</strong> → (51) A61K 31/485<br />

A61K 31/7048 → (51) A61K 31/485<br />

A61K 31/7056 → (51) A61K 31/4709<br />

(51) A61K 31/7076 (11) 2 493 480 A1*<br />

A61P 27/02<br />

(25) En (26) En<br />

(21) 10827379.8 (22) 26.10.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

BA ME<br />

(86) US 2010/054040 26.10.2010<br />

(87) WO 2011/053569 2011/18 05.05.2011<br />

(30) 26.10.2009 US 254923 P<br />

(54) OPHTHALMISCHE FORMULIERUNG UND<br />

HERSTELLUNGSVERFAHREN DAFÜR<br />

OPHTHALMIC FORMULATION AND<br />

METHOD OF MANUFACTURE THEREOF<br />

PRÉPARATION OPHTALMIQUE ET SON<br />

PROCÉDÉ DE FABRICATION<br />

(71) Inotek Pharmaceuticals Corporation, 33<br />

Hayden Avenue, Second Floor, Lexington,<br />

MA 02421, US<br />

(72) AVERY, Kenneth, L., Merrimack, NH 03054,<br />

US<br />

TAKRURI, Harun, Newport Beach, CA 92660,<br />

US<br />

(74) Maiwald <strong>Patent</strong>anwalts GmbH, Elisenhof Elisenstrasse<br />

3, 80335 München, DE<br />

A61K 31/7088 → (51) C12N 15/113<br />

A61K 31/713 → (51) C12N 15/113<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(51) A61K 31/715 (11) 2 493 481 A1*<br />

A61P 35/00<br />

(25) En (26) En<br />

(21) 10773951.8 (22) 26.10.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

(86) GB 2010/001987 26.10.2010<br />

(87) WO 2011/051665 2011/18 05.05.2011<br />

(30) 26.10.2009 GB 0918722<br />

(54) KREBSMITTELZUSAMMENSETZUNG MIT<br />

ALGINAT<br />

ANTI-CANCER COMPOSITION<br />

COMPRISING ALGINATE<br />

COMPOSITION ANTICANCÉREUSE<br />

COMPRENANT DE L'ALGINATE<br />

(71) The University of Birmingham, Edgbaston,<br />

Birmingham B15 2TT, GB<br />

(72) TSELEPIS, Chris, Birmingham West<br />

Midlands B15 2TT, GB<br />

IQBAL, Tariq, Birmingham West Midlands<br />

B15 2TT, GB<br />

SANSOM, Owen James, Glasgow G61 1BD,<br />

GB<br />

(74) Ward, David Ian, Marks & Clerk LLP Alpha<br />

Tower Suffolk Street, Queensway<br />

Birmingham B1 1TT, GB<br />

A61K 31/715 → (51) A23L 1/05<br />

A61K 31/787 → (51) C07F 1/12<br />

A61K 31/79 → (51) A61P 17/02<br />

(51) A61K 33/00 (11) 2 493 482 A1*<br />

A61P 3/00<br />

(25) En (26) En<br />

(21) 10776328.6 (22) 27.10.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

BA ME<br />

(86) EP 2010/066288 27.10.2010<br />

(87) WO 2011/051357 2011/18 05.05.2011<br />

(30) 27.10.2009 DE 102009046058<br />

(54) THERAPEUTISCHES GAS ZUR BEHAND-<br />

LUNG VON MITOCHONDRIENERKRAN-<br />

KUNGEN<br />

THERAPEUTIC GAS FOR THE<br />

TREATMENT OF MITOCHONDRIAL<br />

DISORDERS<br />

GAZ THÉRAPEUTIQUE POUR LE TRAITE-<br />

MENT DE TROUBLES MITOCHONDRIAUX<br />

(71) Cellgym Technologies GmbH, Knesebeckstrasse<br />

68/69, 10623 Berlin, DE<br />

(72) Cellgym Technologies GmbH, 10623 Berlin,<br />

DE<br />

(74) Schubert, Klemens, Müller & Schubert <strong>Patent</strong>anwälte<br />

Neue Promenade 5, 10178 Berlin,<br />

DE<br />

A61K 33/00 → (51) A61K 33/30<br />

A61K 33/10 → (51) A61K 33/30<br />

(51) A61K 33/14 (11) 2 493 483 A2*<br />

A61K 31/35 A61K 31/185<br />

A61K 9/08 A61P 17/00<br />

(25) En (26) En<br />

(21) 10828902.6 (22) 27.10.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

(86) US 2010/054322 27.10.2010<br />

(87) WO 2011/056667 2011/19 12.05.2011<br />

(88) 09.09.2011<br />

(30) 28.10.2009 US 255556 P<br />

44<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>36</strong>/<strong>2012</strong>) 05.09.<strong>2012</strong><br />

(54) TOPISCHE HAUTBEHANDLUNGSFORMU-<br />

LIERUNG FÜR ROSACEA SOWIE ENT-<br />

SPRECHENDES VERFAHREN<br />

ROSACEA TOPICAL SKIN TREATMENT<br />

METHOD AND FORMULATION<br />

MÉTHODE DE TRAITEMENT TOPIQUE<br />

CUTANÉ DE LA ROSACÉE ET COMPOSI-<br />

TION ASSOCIÉE<br />

(71) Guthery, B. Eugene, 3520 Woodridge Drive,<br />

Texarkana, TX 77053-1486, US<br />

(72) Guthery, B. Eugene, Texarkana, TX 77053-<br />

1486, US<br />

(74) Train, Matthew, et al, Reddie & Grose LLP<br />

16 Theobalds Road, London, Greater<br />

London WC1X 8PL, GB<br />

A61K 33/26 → (51) A61P 33/06<br />

(51) A61K 33/30 (11) 2 493 484 A2*<br />

A61K 33/10 A61K 31/195<br />

A61K 33/00 A61K 9/20<br />

A61P 1/04<br />

(25) En (26) En<br />

(21) 10827608.0 (22) 01.11.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

(86) US 2010/054981 01.11.2010<br />

(87) WO 2011/053917 2011/18 05.05.2011<br />

(88) 06.10.2011<br />

(30) 01.11.2009 US 257034 P<br />

(54) GASTRORETENTIVE ZINKPRÄPARATE<br />

ZUR HOCH DOSIERTEN ORALEN VER-<br />

ABREICHUNG<br />

GASTRORETENTIVE ORAL HIGH DOSE<br />

ZINC PREPARATIONS<br />

PRÉPARATIONS ORALES GASTRORÉ-<br />

TENTIVES À TENEUR ÉLEVÉE EN ZINC<br />

(71) Synthetic Biologics, Inc., 3930 Varsity Drive,<br />

Ann Arbor, Michigan 48108, US<br />

(72) BREWER, George, J., Ann Arbor Michigan<br />

48108, US<br />

KANZER, Steve, H., Ann Arbor Michigan<br />

48108, US<br />

LYON, Max, Seattle Washington 98122, US<br />

NEWSOME, David, A., Saint Petersburg<br />

Florida 33704, US<br />

CROUCH, Dennis, Vicksburg Michigan<br />

49097, US<br />

(74) Rands, Peter David, et al, Mintz Levin Cohn<br />

Ferris Glovsky and Popeo Intellectual<br />

Property LLP Alder Castle 10 Noble Street,<br />

London EC2V 7JX, GB<br />

A61K 35/00 → (51) C07F 1/12<br />

A61K 35/12 → (51) C12N 5/071<br />

A61K 35/12 → (51) C12N 5/0797<br />

(51) A61K 35/14 (11) 2 493 485 A1*<br />

A61P 35/00<br />

(25) En (26) En<br />

(21) 09748638.5 (22) 30.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/062868 30.10.2009<br />

(87) WO 2011/053321 2011/18 05.05.2011<br />

(54) VERWENDUNG VON AUTOLOGEN EF-<br />

FEKTORZELLEN ZUR BEHANDLUNG VON<br />

MULTIPLEM MYELOM<br />

USE OF AUTOLOGOUS EFFECTOR CELLS<br />

FOR TREATMENT OF MULTIPLE<br />

MYELOMA<br />

UTILISATION DE CELLULES EFFEC-<br />

TRICES AUTOLOGUES POUR LE TRAITE-<br />

MENT DE MYÉLOME MULTIPLE

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!